Back to ELVN
Patient Square Capital LP → ELVN
Patient Square Capital LP ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$9.7M
Q3 2026
Peak value
$10.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $4.7M |
| Q1 2026 | $7.8M |
| Q2 2026 | $10.8M |
| Q3 2026 | $9.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $9.7M | 212.5K | — | — |
| Q2 2026 | $10.8M | 212.5K | — | — |
| Q1 2026 | $7.8M | 200.0K | — | — |
| Q4 2025 | $4.7M | 308.1K | — | — |
Other funds holding ELVN
$449.6M
$394.2M
$343.9M
$326.4M
$312M
$310.6M
$294.5M
$261.1M